Ionis Pharmaceuticals Inc at Guggenheim Healthcare Talks: Immunology and Neurology Day Transcript
Good afternoon, and welcome to Guggenheim's Fourth Immunology and Neurology Conference. My pleasure to host Onaiza Cadoret, EVP of -- and Chief Global Product Strategy and Operations Officer at Ionis; and Eric Swayze, EVP of Research. So welcome. Thank you -- thank you both for joining us today.
Thank you for inviting us. I appreciate it.
Questions & Answers
So if I could start with you, Eric. Sure. So the dosing array of news items over the last 2 months or so, maybe just for the audience frame us on the overall business -- sort of a business update from the company.
Yes, it'd be great. We have had a pretty event-filled year. I guess, I'd just kind of highlight some of the later-stage programs and maybe a little bit of the technology advancements we've had, starting with eplontersen, which we had positive interim Phase III data out earlier
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
